The invention
Secreted CDCP1 as a blood-borne biomarker for noninvasive diagnosis and precision treatment of Nonalcoholic Steatohepatitis (NASH)
M: Medicine – Surgery – Orthopaedics – Material for disabled
Informations
- Stand number
- B81
- Exhibition class
- M: Medicine – Surgery – Orthopaedics – Material for disabled
- Technical description
- sCDCP1 as a robust biomarker for NASH (the most common chronic liver disease) and development of an ultrasensitive sCDCP1 assay for noninvasive diagnosis of NASH, and a sCDCP1 siRNA nanodrug for treatment of NASH with excellent efficacy.
- Simplified description
- We've identified sCDCP1 as an important marker for diagnosing NASH, a common liver disease. We've also created a highly sensitive test to detect it and a new siRNA-based treatment that shows great promise.
- Video
- Link
Inventors
Aimin XU
inventor 3727293030_3315
The University of Hong Kong
inventor 3727293030_3106
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.